USPTO serial 99386954
V-GATE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 14, 2026
- Examiner
- CAYSIDO, REBECCA TOLENTINO
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with V-GATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MATTHEW HOMYK
MATTHEW HOMYK BLANK ROME LLPOne Logan Square, 130 North 18th StreetPhiladelphia, PA 19103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; Biological preparations for use in industry and science; Protein for industrial use; Protein in raw material form for scientific and medical research; Monoclonal antibodies for scientific purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the manufacture of pharmaceuticals; Chemicals for use in the manufacture of anti-cancer and chemotherapy drugs; Chemical preparations for scientific purposes | ACTIVE | — |
| 005 | Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Anti-cancer preparations; Biopharmaceutical preparations for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for suppressing tumors; Tumor suppressing agents; Chemotherapeutics; Antibodies for medical purposes | ACTIVE | — |
| 009 | Laboratory chemical reactors; Flow meters; Downloadable software for conducting research in chemical engineering; Downloadable software for conducting research in biochemistry; Computer software, recorded, for biochemistry to identify biological characteristics; Computer software, recorded, for chemical engineering to identify biological characteristics; Computer software, recorded, for biochemical engineering to identify biological characteristics; Downloadable software for conducting research in biochemical engineering; Laboratory equipment and supplies, namely, incubators; Computer programs, recorded, for testing chemicals in biochemistry; Computer programs, recorded, for testing chemicals in chemical engineering; Computer programs, recorded, for testing chemicals in biochemical engineering; Computer programs, downloadable, for performing biochemical engineering; Computer programs, downloadable, for performing chemical engineering; Computer programs, downloadable, for performing biochemistry | ACTIVE | — |
| 041 | Publishing of electronic publications; Publishing and issuing of scientific papers in the field of biochemistry; Publishing and issuing of scientific papers in the field of chemical engineering; Publishing and issuing of scientific papers in the field of biochemical engineering; Publishing and issuing of scientific papers in the field of pharmaceuticals; Publishing and issuing of scientific papers in the field of cancer; Publishing and issuing of scientific papers in the field of medicine; Book publishing; Magazine publishing | ACTIVE | — |
| 042 | Scientific laboratory services; Scientific and technological services, namely, research and design in the field of biotechnology; Scientific and technological services, namely, research and design in the field of biology; Scientific and technological services, namely, research and design in the field of biochemistry; Scientific and technological services, namely, research and design in the field of pharmaceuticals; Drug discovery services; Biotechnology research; Biological research; Medical research; Clinical research in the field of cancer; Clinical research in the field of biochemistry; Scientific research for medical purposes in the area of cancerous diseases; Vaccine research and development; Pharmaceutical research and development; Research and development services in the field of antibodies; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical drug development services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Testing of pharmaceuticals; Scientific research consulting in the field of biochemistry; Research and development in the field of biochemistry; Biochemical research and analysis; Research and development in the field of biotechnology; Engineering services in the field of biochemistry; Biological research laboratory services; Medical research laboratory services; Laboratory services for biomanufacturing; Laboratory services for the production of pharmaceuticals; Medical research laboratories; Biochemical research; Scientific research consulting in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmaceutical research | ACTIVE | — |
| 044 | Medical services; Pharmaceutical advice; Medical and pharmaceutical consultation; Medical analysis services for the diagnosis of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Valink Therapeutics Inc.
- Other trademarks owned by Valink Therapeutics Inc.
- Other trademarks owned by Valink Therapeutics Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named V-GATE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 14, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 26, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 30, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 3, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 11, 2025 | NWAP | NEW APPLICATION ENTERED | — |